NORIS, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 8.646
AS - Asia 5.634
EU - Europa 4.411
SA - Sud America 706
Continente sconosciuto - Info sul continente non disponibili 441
AF - Africa 149
OC - Oceania 19
Totale 20.006
Nazione #
US - Stati Uniti d'America 8.357
CN - Cina 2.833
SG - Singapore 1.197
IE - Irlanda 966
HK - Hong Kong 590
IT - Italia 524
FI - Finlandia 514
BR - Brasile 511
DE - Germania 500
UA - Ucraina 487
VN - Vietnam 465
RU - Federazione Russa 395
SE - Svezia 306
FR - Francia 260
GB - Regno Unito 220
CA - Canada 149
IN - India 127
AR - Argentina 87
BD - Bangladesh 86
ZA - Sudafrica 70
IQ - Iraq 53
MX - Messico 37
JP - Giappone 36
NL - Olanda 33
EC - Ecuador 31
TR - Turchia 31
PL - Polonia 30
ES - Italia 28
PK - Pakistan 27
ID - Indonesia 26
SA - Arabia Saudita 24
CO - Colombia 23
UZ - Uzbekistan 21
BE - Belgio 20
PH - Filippine 19
AU - Australia 18
RO - Romania 18
MA - Marocco 16
CZ - Repubblica Ceca 15
JM - Giamaica 14
AT - Austria 13
EG - Egitto 13
VE - Venezuela 12
CR - Costa Rica 11
IR - Iran 11
MY - Malesia 11
PE - Perù 11
AZ - Azerbaigian 10
JO - Giordania 10
KE - Kenya 10
PY - Paraguay 10
TT - Trinidad e Tobago 10
AL - Albania 9
CL - Cile 9
ET - Etiopia 9
EU - Europa 9
GR - Grecia 9
LT - Lituania 9
CH - Svizzera 8
HN - Honduras 8
PA - Panama 8
PR - Porto Rico 8
SV - El Salvador 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
UY - Uruguay 7
EE - Estonia 6
GT - Guatemala 6
KG - Kirghizistan 6
NI - Nicaragua 6
NP - Nepal 6
BB - Barbados 5
DK - Danimarca 5
DZ - Algeria 5
HU - Ungheria 5
KR - Corea 5
KZ - Kazakistan 5
LB - Libano 5
MU - Mauritius 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
IL - Israele 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
LU - Lussemburgo 3
MD - Moldavia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
GE - Georgia 2
GH - Ghana 2
GP - Guadalupe 2
HR - Croazia 2
KH - Cambogia 2
LC - Santa Lucia 2
Totale 19.540
Città #
Dublin 965
San Jose 946
Chandler 874
Ashburn 770
Jacksonville 667
Singapore 658
Nanjing 615
Hong Kong 571
Dallas 533
Council Bluffs 500
Beijing 429
Boardman 284
Nanchang 224
Princeton 198
Shenyang 184
Wilmington 182
Lawrence 180
Medford 178
Munich 176
Los Angeles 168
Changsha 165
Hebei 165
Lauterbourg 165
Ho Chi Minh City 160
Helsinki 156
Jiaxing 128
Hanoi 125
New York 108
Tianjin 97
Milan 95
Hangzhou 91
Ann Arbor 89
Buffalo 79
São Paulo 68
Pavia 67
Shanghai 66
Santa Clara 62
Houston 57
Johannesburg 57
Moscow 56
Redondo Beach 53
Orem 47
Woodbridge 47
Turku 43
Toronto 40
Chennai 35
Montreal 35
Verona 34
Guangzhou 33
Tokyo 33
Atlanta 31
Brooklyn 31
Phoenix 30
Fairfield 29
Rome 29
Seattle 28
The Dalles 28
Chicago 27
Da Nang 27
Denver 27
Norwalk 26
Columbus 25
Frankfurt am Main 25
London 25
San Francisco 23
North Bergen 21
Warsaw 21
Pune 20
Ankara 19
Belo Horizonte 19
Zhengzhou 19
Baghdad 18
Brasília 18
Brussels 18
Manchester 18
Tashkent 18
Falkenstein 17
Mexico City 17
Boston 16
Haiphong 16
Jinan 16
Des Moines 15
Rio de Janeiro 15
Stockholm 15
Naples 14
Brno 13
Falls Church 12
Mumbai 12
Nuremberg 12
Palermo 12
Timisoara 12
Amsterdam 11
Auburn Hills 11
Florence 11
Paris 11
Quito 11
Secaucus 11
Biên Hòa 10
Buenos Aires 10
Cleveland 10
Totale 12.688
Nome #
Anemia in patients with Covid-19: pathogenesis and clinical significance 299
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 196
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 180
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 178
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 171
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 171
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 166
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 162
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 161
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 157
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 153
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 151
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 150
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 148
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 147
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia 147
Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders 146
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 146
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 145
Antigeni minori di istocompatibilità 144
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 143
A HOMOZYGOUS POINT MUTATION IN A LEUCINE-RICH MOTIF OF PLATELET GLYCOPROTEIN-IX ASSOCIATED WITH BERNARD-SOULIER SYNDROME (BSS) 143
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 143
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 140
Spectrum of the mutations in Bernard-Soulier syndrome. 138
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 138
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 138
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 135
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 135
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 134
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 134
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 133
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 132
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 128
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 128
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 128
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 128
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 128
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 128
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 127
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 126
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 126
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 125
A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. 124
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 124
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 124
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 122
Platelet-independent defect in hemostasis associated with sirolimus use 122
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 121
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 120
Inherited thrombocytopenias. The evolving spectrum. 120
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 120
A novel mutation in gp1bb reveals the role of the cytoplasmic domain of gpibβ in the pathophysiology of bernard‐soulier syndrome and gpib‐ix complex assembly 120
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 119
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 119
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 118
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk disorders. In patients the SPATA-DVT with inherited Study platelet 118
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 117
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 117
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 116
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 115
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 114
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 112
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 111
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 111
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 110
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 110
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 109
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 109
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 108
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 108
In vitro and in vivo effects of desmopressin on platelet function 108
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 107
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 107
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 107
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel GFI1B germline mutation 107
Platelet count and aging 106
Malattia di von Willebrand tipo IIb: descrizione di un caso clinico 106
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 106
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 105
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 105
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NATP) CAUSED BY A NEW LOW-FREQUENCY PLATELET-SPECIFIC ALLOANTIGEN, MAXA, LOCATED ON GPIIB 103
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 102
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 102
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 101
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 101
Incompatibility at CD31, HPA3 or HPA5 loci are HLA-A2-restricted risk factors for acute GVHD. 101
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia 101
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 101
null 100
A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders 100
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function 99
Platelet function after in vivo and in vitro treatment with thrombolytic agents 99
ANKRD26-related thrombocytopenia and myeloid malignancies 99
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 98
Platelet Counting and Measurement of Platelet Dimensions 98
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 97
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 97
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 97
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 97
Totale 12.591
Categoria #
all - tutte 86.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022856 0 0 0 17 36 48 14 53 53 35 108 492
2022/20232.615 273 158 15 232 265 271 5 138 1.122 21 67 48
2023/2024890 113 125 33 82 107 240 19 58 11 39 37 26
2024/20252.556 48 230 53 84 52 178 141 201 534 89 321 625
2025/20266.430 499 432 827 731 716 305 1.296 287 524 436 212 165
2026/20271.832 128 406 515 783 0 0 0 0 0 0 0 0
Totale 20.006